CryoTherapeutics receives additional funding of € 12.3 million and launches a new clinical study
February 17, 2022
CEVEC closes growth financing round to serve strong demand in viral vector technologies for cell and gene therapies
July 28, 2021
Wunderflats receives $21 million in growth funding to make it easier for people to access housing in Europe
June 25, 2021
Prostatype Genomics strengthens its product offering by launching P-score Web Service (PWS)
March 26, 2021
SIRION Biotech announces collaboration with Sanofi to innovate gene therapy treatments with improved adeno-associated virus capsids
February 24, 2021
CEVEC and CARISMA Therapeutics sign license agreement for the use of CAP® Technology in anti-tumor cell therapies
February 3, 2021
CEVEC announces new license agreement for its AAV manufacturing technology ELEVECTA® in gene therapy
January 11, 2021
Creathor's portfolio company Alrise Biosystems announces acquisition of its ImSus® drug delivery technology by Ferring International.
December 14, 2020
Cevec signs agreement with Roche for the use of Cevec’s Elevecta® Technology in Gene Therapy
November 12, 2020
CEVEC and Rznomics sign license agreement for the use of CAP® Technology in manufacturing of adenoviral vectors
October 19, 2020
Creathor Ventures portfolio company Prostatype Genomics AB's pre-IPO securities issue oversubscribed
October 7, 2020
vasopharm announces Last Patient Last Visit in NOSTRA III Traumatic Brain Injury Clinical Trial Copy
July 2, 2020
CEVEC announces the launch of the ELEVECTA® Platform – the Stable Producer Cell Line Technology for AAV Gene Therapy Vectors
April 28, 2020
CEVEC signs license agreement for the development and commercialization of exosomes for therapeutic use
April 16, 2020
CEVEC and CellGenix announce the launch of GMP-grade TGF-ß1 for cell and gene therapy applications
December 19, 2019
#MakeItTen: Interview with R3 Communications
November 25, 2019
#MakeItTen: Interview with CEVEC Pharmaceuticals
November 7, 2019
#MakeItTen: Interview with Imverse
October 28, 2019
lengoo, the German AI-first translation tech company, raises €6M additional funding
September 1, 2019
SmartBear aquires our portfolio company Bitbar
August 29, 2019
#MakeItTen: Interview with Allthings Technologies
August 7, 2019
#MakeItTen: Interview with HeyJobs
August 2, 2019
8 million euro investment for Wunderflats, Germany's leading platform for Housing as a Service
July 16, 2019
#MakeItTen: Interview with vasopharm
July 11, 2019
vasopharm Closes € 9.5 million Financing Round
July 11, 2019
#MakeItTen: Interview with Acousia Therapeutics
June 12, 2019
#MakeItTen: Interview with Sirion Biotech
May 29, 2019
#MakeItTen: Interview with Ledgy
May 22, 2019
#MakeItTen: Interview with lengoo
May 13, 2019
SIRION Biotech and Denali Therapeutics Join Forces
January 9, 2019
Blueprint Genetics strengthens its pharmaceutical expertise with new Chairman and a Senior Advisor
December 10, 2018
iFunded raises €4 million growth capital to extend its offer to institutional investors
September 25, 2018
Creathor invests in Acousia Therapeutics to fight hearing loss in €10 million financing round
May 14, 2018
Creathor joins SICTIC
April 18, 2018
Creathor invests in ehealth platform „HUMANOO“
January 30, 2018
Allthings implements digital solution at business properties of Credit Suisse Global Real Estate
September 28, 2017
AYOXXA launches LUNARIS Mouse 12-Plex Th17 Kit
September 22, 2017
Karlheinz answers questions about biotech investment trends
September 21, 2017
Phenex announces milestone payment from Janssen
July 10, 2017
Karlheinz on the marathon trade sale exit of Sividon
April 21, 2017
Cédric talks about Creathor’s strategy in Berlin Valley
April 21, 2017
R3 selected to join Startup Autobahn Program #2
February 27, 2017
CEVEC licenses CAP® technologies for Zika virus vaccines
February 9, 2017
Creathor and IBB Bet invest in R3 Communications
January 23, 2017
Phenex receives $100 million milestone payment from Gilead
January 5, 2017
Wunderflats receives $21 million in growth funding to make it easier for people to access housing in Europe
June 25, 2021
#MakeItTen: Interview with R3 Communications
November 25, 2019
#MakeItTen: Interview with Imverse
October 28, 2019
lengoo, the German AI-first translation tech company, raises €6M additional funding
September 1, 2019
SmartBear aquires our portfolio company Bitbar
August 29, 2019
#MakeItTen: Interview with Allthings Technologies
August 7, 2019
#MakeItTen: Interview with HeyJobs
August 2, 2019
8 million euro investment for Wunderflats, Germany's leading platform for Housing as a Service
July 16, 2019
#MakeItTen: Interview with Ledgy
May 22, 2019
#MakeItTen: Interview with lengoo
May 13, 2019
Blueprint Genetics strengthens its pharmaceutical expertise with new Chairman and a Senior Advisor
December 10, 2018
iFunded raises €4 million growth capital to extend its offer to institutional investors
September 25, 2018
Creathor invests in ehealth platform „HUMANOO“
January 30, 2018
Allthings implements digital solution at business properties of Credit Suisse Global Real Estate
September 28, 2017
R3 selected to join Startup Autobahn Program #2
February 27, 2017
Creathor and IBB Bet invest in R3 Communications
January 23, 2017
CryoTherapeutics receives additional funding of € 12.3 million and launches a new clinical study
February 17, 2022
CEVEC closes growth financing round to serve strong demand in viral vector technologies for cell and gene therapies
July 28, 2021
Prostatype Genomics strengthens its product offering by launching P-score Web Service (PWS)
March 26, 2021
SIRION Biotech announces collaboration with Sanofi to innovate gene therapy treatments with improved adeno-associated virus capsids
February 24, 2021
CEVEC and CARISMA Therapeutics sign license agreement for the use of CAP® Technology in anti-tumor cell therapies
February 3, 2021
CEVEC announces new license agreement for its AAV manufacturing technology ELEVECTA® in gene therapy
January 11, 2021
Creathor's portfolio company Alrise Biosystems announces acquisition of its ImSus® drug delivery technology by Ferring International.
December 14, 2020
Cevec signs agreement with Roche for the use of Cevec’s Elevecta® Technology in Gene Therapy
November 12, 2020
CEVEC and Rznomics sign license agreement for the use of CAP® Technology in manufacturing of adenoviral vectors
October 19, 2020
Creathor Ventures portfolio company Prostatype Genomics AB's pre-IPO securities issue oversubscribed
October 7, 2020
vasopharm announces Last Patient Last Visit in NOSTRA III Traumatic Brain Injury Clinical Trial Copy
July 2, 2020
CEVEC announces the launch of the ELEVECTA® Platform – the Stable Producer Cell Line Technology for AAV Gene Therapy Vectors
April 28, 2020
CEVEC signs license agreement for the development and commercialization of exosomes for therapeutic use
April 16, 2020
CEVEC and CellGenix announce the launch of GMP-grade TGF-ß1 for cell and gene therapy applications
December 19, 2019
#MakeItTen: Interview with CEVEC Pharmaceuticals
November 7, 2019
#MakeItTen: Interview with vasopharm
July 11, 2019
vasopharm Closes € 9.5 million Financing Round
July 11, 2019
#MakeItTen: Interview with Acousia Therapeutics
June 12, 2019
#MakeItTen: Interview with Sirion Biotech
May 29, 2019
SIRION Biotech and Denali Therapeutics Join Forces
January 9, 2019
Blueprint Genetics strengthens its pharmaceutical expertise with new Chairman and a Senior Advisor
December 10, 2018
Creathor invests in Acousia Therapeutics to fight hearing loss in €10 million financing round
May 14, 2018
Creathor invests in ehealth platform „HUMANOO“
January 30, 2018
AYOXXA launches LUNARIS Mouse 12-Plex Th17 Kit
September 22, 2017
Karlheinz answers questions about biotech investment trends
September 21, 2017
Phenex announces milestone payment from Janssen
July 10, 2017
Karlheinz on the marathon trade sale exit of Sividon
April 21, 2017
CEVEC licenses CAP® technologies for Zika virus vaccines
February 9, 2017
Phenex receives $100 million milestone payment from Gilead
January 5, 2017
#MakeItTen: Interview with R3 Communications
November 25, 2019
#MakeItTen: Interview with CEVEC Pharmaceuticals
November 7, 2019
#MakeItTen: Interview with Imverse
October 28, 2019
lengoo, the German AI-first translation tech company, raises €6M additional funding
September 1, 2019
SmartBear aquires our portfolio company Bitbar
August 29, 2019
#MakeItTen: Interview with Allthings Technologies
August 7, 2019
#MakeItTen: Interview with HeyJobs
August 2, 2019
8 million euro investment for Wunderflats, Germany's leading platform for Housing as a Service
July 16, 2019
#MakeItTen: Interview with vasopharm
July 11, 2019
vasopharm Closes € 9.5 million Financing Round
July 11, 2019
#MakeItTen: Interview with Acousia Therapeutics
June 12, 2019
#MakeItTen: Interview with Sirion Biotech
May 29, 2019
#MakeItTen: Interview with Ledgy
May 22, 2019
#MakeItTen: Interview with lengoo
May 13, 2019
Creathor joins SICTIC
April 18, 2018
Karlheinz answers questions about biotech investment trends
September 21, 2017
Karlheinz on the marathon trade sale exit of Sividon
April 21, 2017
Cédric talks about Creathor’s strategy in Berlin Valley
April 21, 2017